These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 23183050)

  • 1. 100 years of immunotherapy: the Monaco charter. under the high patronage of His Serene Highness Prince Albert II of Monaco.
    Canonica GW; Baena-Cagnani CE; Compalati E; Bohle B; Bonini S; Bousquet J; Cox L; Fink-Wagner AH; González Díaz S; Jacobsen L; Passalacqua G; Pawankar R; Vieths S; Yusuf O; Zuberbier T
    Int Arch Allergy Immunol; 2013; 160(4):346-9. PubMed ID: 23183050
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regulatory cells in allergen-specific immunotherapy.
    Soyka MB; Holzmann D; Akdis CA
    Immunotherapy; 2012 Apr; 4(4):389-96. PubMed ID: 22512633
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A review of allergy and allergen specific immunotherapy.
    Bidad K; Nicknam MH; Farid R
    Iran J Allergy Asthma Immunol; 2011 Mar; 10(1):1-9. PubMed ID: 21358009
    [TBL] [Abstract][Full Text] [Related]  

  • 4. History of immunotherapy: the first 100 years.
    Fitzhugh DJ; Lockey RF
    Immunol Allergy Clin North Am; 2011 May; 31(2):149-57, vii. PubMed ID: 21530811
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Allergen immunotherapy.
    Frew AJ
    J Allergy Clin Immunol; 2010 Feb; 125(2 Suppl 2):S306-13. PubMed ID: 20176266
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunotherapy: The meta-analyses. What have we Learned?
    Calderón MA; Boyle RJ; Penagos M; Sheikh A
    Immunol Allergy Clin North Am; 2011 May; 31(2):159-73, vii. PubMed ID: 21530812
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Allergen-related approaches to immunotherapy.
    Rolland JM; Gardner LM; O'Hehir RE
    Pharmacol Ther; 2009 Mar; 121(3):273-84. PubMed ID: 19111571
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hundred years of allergen immunotherapy.
    Frew AJ
    Clin Exp Allergy; 2011 Sep; 41(9):1221-5. PubMed ID: 21554436
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunotherapy concepts under investigation.
    Kündig TM
    Allergy; 2011 Jul; 66 Suppl 95():60-2. PubMed ID: 21668859
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Molecular-allergological aspects of allergen-specific immunotherapy].
    Jappe U
    Hautarzt; 2017 Apr; 68(4):271-281. PubMed ID: 28293695
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Allergen-specific immunotherapy or desensitization].
    Demoly P; Michel FB
    Bull Acad Natl Med; 2009 May; 193(5):1127-44; discussion 1144-5. PubMed ID: 20120392
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Adjuvants].
    Brehler R
    Hautarzt; 2017 Apr; 68(4):292-296. PubMed ID: 28130604
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Developments in allergen-specific immunotherapy: from allergen extracts to allergy vaccines bypassing allergen-specific immunoglobulin E and T cell reactivity.
    Focke M; Swoboda I; Marth K; Valenta R
    Clin Exp Allergy; 2010 Mar; 40(3):385-97. PubMed ID: 20210812
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Use of A-type CpG oligodeoxynucleotides as an adjuvant in allergen-specific immunotherapy in humans: a phase I/IIa clinical trial.
    Senti G; Johansen P; Haug S; Bull C; Gottschaller C; Müller P; Pfister T; Maurer P; Bachmann MF; Graf N; Kündig TM
    Clin Exp Allergy; 2009 Apr; 39(4):562-70. PubMed ID: 19226280
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [GUIDE TO ALLERGEN IMMUNOTHERAPY FOR MITE ALLERGY].
    Gotoh M
    Arerugi; 2017; 66(6):788-791. PubMed ID: 28701643
    [No Abstract]   [Full Text] [Related]  

  • 16. What should drive the choice of allergen for immunotherapy in polysensitized patients?
    Ciprandi G; Incorvaia C; Puccinelli P; Dell'Albani I; Frati F
    Ann Allergy Asthma Immunol; 2012 Aug; 109(2):148-9. PubMed ID: 22840259
    [No Abstract]   [Full Text] [Related]  

  • 17. Mechanisms of subcutaneous allergen immunotherapy.
    Soyer OU; Akdis M; Akdis CA
    Immunol Allergy Clin North Am; 2011 May; 31(2):175-90, vii-viii. PubMed ID: 21530813
    [TBL] [Abstract][Full Text] [Related]  

  • 18. T regulatory cells in allergen-specific immunotherapy.
    Verhagen J; Taylor A; Blaser K; Akdis M; Akdis CA
    Int Rev Immunol; 2005; 24(5-6):533-48. PubMed ID: 16318994
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of recombinant and native timothy pollen (rPhl p 1, 2, 5, 6, 7, 11, 12 and nPhl p 4)- specific IgG4 antibodies induced by subcutaneous immunotherapy with timothy pollen extract in allergic patients.
    Rossi RE; Monasterolo G
    Int Arch Allergy Immunol; 2004 Sep; 135(1):44-53. PubMed ID: 15286445
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Allergen immunotherapy practice in the United States: guidelines, measures, and outcomes.
    Cox L; Esch RE; Corbett M; Hankin C; Nelson M; Plunkett G
    Ann Allergy Asthma Immunol; 2011 Oct; 107(4):289-99; quiz 300. PubMed ID: 21962088
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.